An interventional study of Cala ONE Device in Essential Tremor, sponsored by Cala Health, Inc.. Completed at 4 sites in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2023-07-18.
Sponsored by Cala Health, Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 146 studies in Essential Tremor with a site in United States — 40 open to participants now, 46 under way, 1 of them phase 3. Essential Tremor · United States.
Among the 146 studies in Essential Tremor with a site in United States, this one is the 23rd largest by enrollment of the 104 interventional ones that give a count, is one of 9 that started in 2016, is one of 60 with no phase, and was the 58th registered.
272 studies on the registry are indexed under Essential Tremor; 75 are open to participants now.
Browse Essential Tremor studies →40 of the 146 studies in Essential Tremor with a site in United States are open now. Recruiting first, the newest first:
Encora, Inc. · Sites in United States
Ages 18+
AbbVie · Sites in United States, Canada
Ages 18–85
University of California, Los Angeles · Sites in United States
Ages 18–90
CND Life Sciences · Sites in United States
Ages 50–85
Boston University Charles River Campus · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 61 Essential Tremor studies recruiting now, 32 (52%) set no upper age limit and 5 (8%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.
This study: 22 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
146 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 14 · Phase 2 27 · Phase 3 5 · Phase 4 5
First in 2000; this study’s year is marked. 9 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 93 is above the median of 25 across 189 interventional studies indexed under Essential Tremor.
Median enrollment 30 across the 104 interventional studies, 81 across the 41 observational. Of the 86 that completed or were terminated, 39 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
47 of 146 have an industry lead sponsor. The 10 most frequent:
Cala Health, Inc. is the lead sponsor of 8 studies on the registry; none are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.
Cala Health, Inc. has 5 studies filed under Essential Tremor — fewer than ten, so there is no comparison to draw.
13 of the studies in Essential Tremor with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03778060Mayo ClinicLong-Term Transcutaneous Stimulation and Essential Tremor: A PET Study | 2026-12 |
| NCT07599592University of California, Los AngelesOpen Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor | 2026-12-31 |
| NCT07428447CND Life SciencesAnalysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease | 2027-02 |
| NCT04286308Massachusetts General HospitalCortical-Basal Ganglia Speech Networks | 2027-02 |
| NCT02553525Duke UniversityEffects of Stimulation Patterns of Deep Brain Stimulation | 2027-03 |
Add all 13 to your calendar (.ics) → With an account.
Among the 146 studies in Essential Tremor with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study evaluates the safety and effectiveness of the Cala ONE device to aid in the symptomatic relief of hand tremors in adult essential tremor subjects. This study is a prospective, randomized, double-blinded, sham-controlled study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects already taking medications for their essential tremor will remain on their medications during the study with no changes in medication type or dosage levels.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Temporal Afferent Patterned Stimulation (TAPS) is alternating bursts of TENS stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.
Device: Cala ONE Device
0 amplitude stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.
Device: Cala ONE Device
The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes.
Change in TETRAS Spiral Rating After Stimulation
The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and after 40 minute stimulation session
Change in TETRAS Spiral Rating During Stimulation
An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and 30 minutes into stimulation session
Self-report Improvement
The percentage of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group. The Clinical Global Impression - Improvement (GGI-I) scale evaluates a clinician's rating of tremor improvement noted in the subject, as a result of the treatment. The scale ranges from 1 (very much improved) to 7 (very much worse).
Time frame: Immediately before and after 40 minute stimulation session
Change in Kinetic Tremor
The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and after 40 minute stimulation session
Change in Kinetic Tremor
The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and 30 minutes into stimulation session
Change in Lateral "Wing Beating" Postural Tremor
The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and after 40 minute stimulation session
Change in Lateral "Wing Beating" Postural Tremor
The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and 30 minutes into stimulation session
Change in Forward Outstretched Postural Tremor
The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and after 40 minute stimulation session
Change in Forward Outstretched Postural Tremor
The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Time frame: Immediately before and 30 minutes into stimulation session
Change in Bain & Findley ADL: Use a Spoon to Drink Liquid
The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Hold a Cup of Liquid
The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Pouring
The change in tremor severity on pouring as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Dialing
The change in tremor severity on dialing a telephone as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Picking up Change
The change in tremor severity on picking up change as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Inserting Plug Into Socket
The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
Change in Bain & Findley ADL: Unlocking
The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Time frame: Immediately before and after 40 minute stimulation session
| Milestone | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Started | 48 | 45 |
| Completed | 48 | 44 |
| Not completed | 0 | 1 |
The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.95 ± 0.68 | 2.63 ± 0.52 |
| Post Stimulation | 2.41 ± 1 | 2.23 ± 0.80 |
An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.95 ± 0.68 | 2.63 ± 0.52 |
| During Stimulation | 2.58 ± 0.90 | 2.26 ± 0.67 |
The percentage of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group. The Clinical Global Impression - Improvement (GGI-I) scale evaluates a clinician's rating of tremor improvement noted in the subject, as a result of the treatment. The scale ranges from 1 (very much improved) to 7 (very much worse).
| Participants | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Self-report Improvement | 35 | 23 |
The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.29 ± 0.47 | 2.27 ± 0.47 |
| Change after stimulation | -0.53 ± 0.59 | -0.34 ± 0.43 |
The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.29 ± 0.47 | 2.27 ± 0.47 |
| Change during stimulation | -0.50 ± 0.51 | -0.53 ± 0.59 |
The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.29 ± 0.70 | 2.16 ± 0.57 |
| Change after stimulation | -0.56 ± 0.72 | -0.36 ± 0.54 |
The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.29 ± 0.70 | 2.16 ± 0.57 |
| Change during stimulation | -0.51 ± 0.70 | -0.34 ± 0.44 |
The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 1.96 ± 0.54 | 1.91 ± 0.54 |
| Change after stimulation | -0.75 ± 0.65 | -0.35 ± 0.51 |
The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 1.96 ± 0.54 | 1.91 ± 0.54 |
| Change during stimulation | -0.56 ± 0.59 | -0.35 ± 0.41 |
The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 3.18 ± 0.78 | 3.00 ± 0.85 |
| Change after stimulation | -0.78 ± 0.89 | -0.59 ± 0.76 |
The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.95 ± 0.85 | 2.65 ± 0.92 |
| Change after stimulation | -1.03 ± 0.73 | -0.57 ± 0.80 |
The change in tremor severity on pouring as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.78 ± 1.03 | 2.59 ± 0.86 |
| Change after stimulation | -0.70 ± 0.76 | -0.59 ± 0.72 |
The change in tremor severity on dialing a telephone as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.23 ± 0.89 | 2.00 ± 0.91 |
| Change after stimulation | -0.70 ± 0.79 | -0.30 ± 0.62 |
The change in tremor severity on picking up change as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.03 ± 0.86 | 1.92 ± 0.89 |
| Change after stimulation | -0.53 ± 0.68 | -0.05 ± 0.62 |
The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 1.83 ± 0.78 | 1.76 ± 0.80 |
| Change after stimulation | -0.33 ± 0.69 | -0.24 ± 0.55 |
The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
| score on a scale | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Baseline | 2.23 ± 0.86 | 1.86 ± 0.67 |
| Change after stimulation | -0.60 ± 0.87 | -0.16 ± 0.55 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| TAPS Stimulation | — | 0/48 (0%) | 2/48 (4.2%) |
| Sham Stimulation | — | 0/45 (0%) | 1/45 (2.2%) |
| Event | TAPS Stimulation | Sham Stimulation |
|---|---|---|
| Skin IrritationSkin and subcutaneous tissue disorders | 2/48 | 0/45 |
| Stinging pain in wristSkin and subcutaneous tissue disorders | 0/48 | 1/45 |
| Feeling of weakness around the wristNervous system disorders | 1/48 | 0/45 |
| Age, Categorical(Participants) | TAPS Stimulation | Sham Stimulation | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 12 | 12 | 24 |
| >=65 years | 36 | 33 | 69 |
| Age, Continuous(years) | TAPS Stimulation | Sham Stimulation | Total |
|---|---|---|---|
| Mean | 70.5 ± 11.2 | 69.8 ± 10.1 | 70.2 ± 10.6 |
| Sex: Female, Male(Participants) | TAPS Stimulation | Sham Stimulation | Total |
|---|---|---|---|
| Female | 25 | 23 | 48 |
| Male | 23 | 22 | 45 |
| Ethnicity (NIH/OMB)(Participants) | TAPS Stimulation | Sham Stimulation | Total |
|---|---|---|---|
| Hispanic or Latino | 2 | 0 | 2 |
| Not Hispanic or Latino | 45 | 45 | 90 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Race (NIH/OMB)(Participants) | TAPS Stimulation | Sham Stimulation | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 1 | 1 |
| Asian | 0 | 1 | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 47 | 41 | 88 |
| More than one race | 1 | 2 | 3 |
| Unknown or Not Reported | 0 | 0 | 0 |
Plan to share: No — Data will be published, but no PHI will be made available.
No publications or documents are linked to this record.
The record gives a start of Apr 2016, a primary completion of Nov 2016 and a completion of Nov 2016. It does not say whether these dates are actual or estimated.
Results were first posted in Jul 2023, 6 years 8 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cala Health, Inc.